Semler Scientific Aims to Accumulate 105,000 BTC by 2027 via Debt and Cash Flow
Semler Scientific, a Santa Clara–based biotech SPAC, plans to build a 105,000-BTC treasury by end-2027. Since May 2024 the firm has steadily accumulated Bitcoin, including a 3,000-BTC purchase in Q1 2024 and 871 BTC in February 2025. It currently holds over $468 million worth of BTC at an average price of $92,158, ranking it fourth among U.S. corporate Bitcoin treasuries. CEO Kristjan Peurst outlined a phased acquisition strategy that adjusts monthly buy allocations based on market price and volatility. Semler will fund Bitcoin purchases through convertible debt, equity offerings and operating cash flow while keeping its debt-to-treasury ratio below 20%. The company targets 10,000 BTC by end-2025 and expects Bitcoin’s growing adoption as a store of value to strengthen its balance sheet and returns. Semler’s move reinforces institutional confidence in Bitcoin and may prompt other mid-cap firms to adopt similar corporate Bitcoin strategies.
Bullish
Semler’s commitment to accumulate 105,000 BTC over a multi-year timetable underlines strong institutional demand for Bitcoin. In the short term, steady corporate buying can support price floors by absorbing circulating supply. Over the long term, a significant Bitcoin treasury funded by debt and cash flow signals confidence in Bitcoin’s store-of-value narrative, likely attracting more corporate treasuries and reinforcing a bullish market structure.